HHS-OIG Settlement with Veloxis Pharmaceuticals: HCP Engagement & Transparency Reporting Lessons

What the Veloxis Case Reveals for Life Sciences Companies The Veloxis enforcement record provides a practical example of how HCP engagement activity can become a Transparency Reporting and enforcement issue. Veloxis had internal meal limits and policies, yet the government alleged, and Veloxis admitted, that employees circumvented those controls by changing attendee lists, omitting physicians, […]